BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 7531945)

  • 21. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
    Brown LF; Tognazzi K; Dvorak HF; Harrist TJ
    Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer.
    Obermair A; Kohlberger P; Bancher-Todesca D; Tempfer C; Sliutz G; Leodolter S; Reinthaller A; Kainz C; Breitenecker G; Gitsch G
    Gynecol Oncol; 1996 Nov; 63(2):204-9. PubMed ID: 8910628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
    Rizk B; Aboulghar M; Smitz J; Ron-El R
    Hum Reprod Update; 1997; 3(3):255-66. PubMed ID: 9322101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular permeability factor, tumor angiogenesis and stroma generation.
    Senger DR; Brown LF; Claffey KP; Dvorak HF
    Invasion Metastasis; 1994-1995; 14(1-6):385-94. PubMed ID: 7544775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.
    Berse B; Brown LF; Van de Water L; Dvorak HF; Senger DR
    Mol Biol Cell; 1992 Feb; 3(2):211-20. PubMed ID: 1550962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression.
    Goldman CK; Bharara S; Palmer CA; Vitek J; Tsai JC; Weiss HL; Gillespie GY
    Neurosurgery; 1997 Jun; 40(6):1269-77. PubMed ID: 9179901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome.
    Neulen J; Yan Z; Raczek S; Weindel K; Keck C; Weich HA; Marmé D; Breckwoldt M
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1967-71. PubMed ID: 7775647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis.
    Claffey KP; Brown LF; del Aguila LF; Tognazzi K; Yeo KT; Manseau EJ; Dvorak HF
    Cancer Res; 1996 Jan; 56(1):172-81. PubMed ID: 8548760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiogenesis and vascular endothelial growth factor expression in the equine corpus luteum.
    Al-zi'abi MO; Watson ED; Fraser HM
    Reproduction; 2003 Feb; 125(2):259-70. PubMed ID: 12578540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells.
    Laitinen M; Ristimäki A; Honkasalo M; Narko K; Paavonen K; Ritvos O
    Endocrinology; 1997 Nov; 138(11):4748-56. PubMed ID: 9348202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels.
    Dvorak HF; Sioussat TM; Brown LF; Berse B; Nagy JA; Sotrel A; Manseau EJ; Van de Water L; Senger DR
    J Exp Med; 1991 Nov; 174(5):1275-8. PubMed ID: 1940805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiogenesis in the human corpus luteum: localization and changes in angiopoietins, tie-2, and vascular endothelial growth factor messenger ribonucleic acid.
    Wulff C; Wilson H; Largue P; Duncan WC; Armstrong DG; Fraser HM
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4302-9. PubMed ID: 11095472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions.
    Brown LF; Olbricht SM; Berse B; Jackman RW; Matsueda G; Tognazzi KA; Manseau EJ; Dvorak HF; Van de Water L
    J Immunol; 1995 Mar; 154(6):2801-7. PubMed ID: 7876550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
    Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
    Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema.
    Provias J; Claffey K; delAguila L; Lau N; Feldkamp M; Guha A
    Neurosurgery; 1997 May; 40(5):1016-26. PubMed ID: 9149260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Periovulatory and interleukin-1 beta-dependent up-regulation of intraovarian vascular endothelial growth factor (VEGF) in the rat: potential role for VEGF in the promotion of periovulatory angiogenesis and vascular permeability.
    Levitas E; Chamoun D; Udoff LC; Ando M; Resnick CE; Adashi EY
    J Soc Gynecol Investig; 2000; 7(1):51-60. PubMed ID: 10732316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preovulatory treatment of mice with anti-VEGF receptor 2 antibody inhibits angiogenesis in corpora lutea.
    Zimmermann RC; Hartman T; Bohlen P; Sauer MV; Kitajewski J
    Microvasc Res; 2001 Jul; 62(1):15-25. PubMed ID: 11421657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis.
    Dvorak HF; Nagy JA; Feng D; Brown LF; Dvorak AM
    Curr Top Microbiol Immunol; 1999; 237():97-132. PubMed ID: 9893348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.